Biotech company Inversago Pharma raises $70m in Series C financing

New Enterprise Associates led the round.

17 October 2022•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Canada North America Deals & Exits Briefs